A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
Withdrawn
- Conditions
- Multiple Sclerosis
- Registration Number
- NCT01539395
- Lead Sponsor
- MSDx, Inc.
- Brief Summary
This is a Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Age 45 years or older of either gender and of any racial/ethnic group.
- Subjects must be in generally good health.
- Subjects must be able and willing to comply with the requirements of the protocol.
- Must be diagnosed with RRMS
- Meets the criteria to enter Group 1 or Group 2
Exclusion Criteria
- Subject is currently in middle of an active episode of an autoimmune condition (e.g. rheumatoid arthritis, system lupus erythematosis)
- Subject currently has a condition such as active influenza that would stimulate the immune system
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biomarker Differential Baseline A difference in the levels of Complex-1 between subjects with controlled, stable MS vs. subjects in acute MS relapse
- Secondary Outcome Measures
Name Time Method Biomarker reduction with steroid therapy 3 months A decrease in the level of MSDx Complex-1 in response to steroid therapy for a relapse of MS.
Trial Locations
- Locations (1)
Northwest NeuroSpecialists, PLLC
🇺🇸Tucson, Arizona, United States
Northwest NeuroSpecialists, PLLC🇺🇸Tucson, Arizona, United States